Elanco Animal Health Incorporated logo

Elanco Animal Health Incorporated

TickerELANVenueUSSectorHealthcarePrimary listingBeta1.68
$23.58+0.11%
FinScore53

Elanco Animal Health Incorporated is a United States-based company in the Healthcare sector with a market capitalisation of $11.8B. Its FinScore is 53/100; its highest-scoring layer is Momentum (60) and its lowest is Value (48).

Market cap
$11.8B
P/E (TTM)
n.m.
Negative TTM earnings
ROE
-3.0%

Share price performance

Loading chart…

About Elanco Animal Health Incorporated

www.elanco.com

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.

Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
HQ
United States
Fiscal year-end
December
Trading currency
USD
Reporting currency
USD
Fundamentals updated
24 days ago
Market
Market cap
$11.8B
Shares outstanding
499.4M
Beta (issuer)
1.71
Revenue (latest FY)
$4.7B

Revenue breakdown

FY 2025$4.7B
  • Non-US
    52.6%$2.5B
  • UNITED STATES
    47.4%$2.2B

FinScore

As of 2026-10-19
Overall53
Quality56
Growth52
Value48
Momentum60
Relative Strength52

Snapshot

Ownership

As of 2026-06-30
Institutional
100.0%
Insider
0.2%
Free float
99.0%
Top-5 institutional holders
49.7%
Shares outstanding
499.4M
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.